Paper36766747
Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
Coleman KL and 10 others. Cells, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance. Papers, record 36766747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36766747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phosphorylation of IGFBP-3 by Casein Kinase 2 Blocks Its Interaction with Hyaluronan, Enabling HA-CD44 Signaling Leading to Increased NSCLC Cell Survival and Cisplatin Resistance.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Humans | |
| Cisplatin | |
| Casein Kinase II | |
| Phosphorylation | |
| Hyaluronic Acid | |
| Proto-Oncogene Proteins c-akt | |
| Insulin-Like Growth Factor Binding Protein 3 | |
| Cell Survival | |
| Tumor Suppressor Protein p53 | |
| Phosphatidylinositol 3-Kinases | |
| Hyaluronan Receptors |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| R15 GM131222 | NIGMS NIH HHS | United States | R15GM131222 | PubMed and NIH |
| R15GM131222 | NIH HHS | United States | R15GM131222 | PubMed and NIH |
Source NIH RePORTER
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19847165 | Requirement for NF-kappaB signalling in a mouse model of lung adenocarcinoma. | Nature | 2009 | https://conductscience.org/library/papers/19847165 | PubMed |
| 2 | 19776744 | The first 30 years of p53: growing ever more complex. | Nat Rev Cancer | 2009 | https://conductscience.org/library/papers/19776744 | PubMed |
| 3 | 25868577 | Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25868577 | PubMed |
| 4 | 29747682 | The biology and role of CD44 in cancer progression: therapeutic implications. | J Hematol Oncol | 2018 | https://conductscience.org/library/papers/29747682 | PubMed |
| 5 | 32383868 | Humanin Blocks the Aggregation of Amyloid-β Induced by Acetylcholinesterase, an Effect Abolished in the Presence of IGFBP-3. | Biochemistry | 2020 | https://conductscience.org/library/papers/32383868 | PubMed |
| 6 | 9417085 | Identification of CD44 residues important for hyaluronan binding and delineation of the binding site. | J Biol Chem | 1998 | https://conductscience.org/library/papers/9417085 | PubMed |
| 7 | 24505115 | Phosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma. | Mol Cell Proteomics | 2014 | https://conductscience.org/library/papers/24505115 | PubMed |
| 8 | 32075247 | p53's Extended Reach: The Mutant p53 Secretome. | Biomolecules | 2020 | https://conductscience.org/library/papers/32075247 | PubMed |
| 9 | 15774585 | Protein kinase casein kinase 2 holoenzyme produced ectopically in human cells can be exported to the external side of the cellular membrane. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/15774585 | PubMed |
| 10 | 22947857 | Distinct kinetic and molecular requirements govern CD44 binding to hyaluronan versus fibrin(ogen). | Biophys J | 2012 | https://conductscience.org/library/papers/22947857 | PubMed |
| 11 | 7532580 | Insulin-like growth factor-binding protein-3 production by MCF-7 breast cancer cells: stimulation by retinoic acid and cyclic adenosine monophosphate and differential effects of estradiol. | Endocrinology | 1995 | https://conductscience.org/library/papers/7532580 | PubMed |
| 12 | 33958632 | Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells. | Sci Rep | 2021 | https://conductscience.org/library/papers/33958632 | PubMed |
| 13 | 31277672 | Role of protein kinase CK2 in antitumor drug resistance. | J Exp Clin Cancer Res | 2019 | https://conductscience.org/library/papers/31277672 | PubMed |
| 14 | 28641565 | D-Amino Acid Analogues of the Antimicrobial Peptide CDT Exhibit Anti- Cancer Properties in A549, a Human Lung Adenocarcinoma Cell Line. | Protein Pept Lett | 2017 | https://conductscience.org/library/papers/28641565 | PubMed |
| 15 | 31579410 | The CK2 inhibitor CX4945 reverses cisplatin resistance in the A549/DDP human lung adenocarcinoma cell line. | Oncol Lett | 2019 | https://conductscience.org/library/papers/31579410 | PubMed |
| 16 | 32592613 | Biochemical determinants of the IGFBP-3-hyaluronan interaction. | FEBS Open Bio | 2020 | https://conductscience.org/library/papers/32592613 | PubMed |
| 17 | 15935690 | IGF-binding proteins--the pieces are falling into place. | Trends Endocrinol Metab | 2005 | https://conductscience.org/library/papers/15935690 | PubMed |
| 18 | 27220886 | Expression of the receptor for hyaluronic acid mediated motility (RHAMM) is associated with poor prognosis and metastasis in non-small cell lung carcinoma. | Oncotarget | 2016 | https://conductscience.org/library/papers/27220886 | PubMed |
| 19 | 18490190 | Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. | Drug Resist Updat | 2008 | https://conductscience.org/library/papers/18490190 | PubMed |
| 20 | 19556345 | Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation. | Mol Endocrinol | 2009 | https://conductscience.org/library/papers/19556345 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42836203 | IGFBP3 and cisplatin synergistically suppress HeLa cell proliferation and migration through NRF2 inhibition. | Res Pharm Sci | 2026 | https://conductscience.org/library/papers/42836203 | PubMed |
| 42829402 | Ru3: a novel ruthenium-based compound overcomes cisplatin resistance in non-small cell lung cancer via the E2F2-IGFBP3-GPX4 pathway. | Apoptosis | 2026 | https://conductscience.org/library/papers/42829402 | PubMed |
| 41303585 | Nicotine-Induced VEGF Levels in NSCLC Cells Are Modulated by PKA, Hyaluronan, and p53. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303585 | PubMed |
| 40985115 | Lactoferrin treatment activates acetylcholinesterase, decreasing acetylcholine levels in non-small cell lung cancer (NSCLC) cell culture supernatants, inhibiting cell survival. | FEBS Open Bio | 2026 | https://conductscience.org/library/papers/40985115 | PubMed |
| 40733153 | Dual-Action Tocilizumab-Conjugated Cisplatin Nanoparticles Overcome Chemoresistance and Metastasis in Non-Small-Cell Lung Cancer. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733153 | PubMed |
| 40503041 | IGFBP3 modulation of tumor pathogenesis and cell signaling pathways (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/40503041 | PubMed |
| 40417926 | Insulin‑like growth factor in cancer: New perspectives (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40417926 | PubMed |
| 40369674 | Role of tumor microenvironment in ovarian cancer metastasis and clinical advancements. | J Transl Med | 2025 | https://conductscience.org/library/papers/40369674 | PubMed |
| 40321073 | Visualization of the Relationship Between Hyaluronic Acid and Wound Healing: A Bibliometric Analysis. | Skin Res Technol | 2025 | https://conductscience.org/library/papers/40321073 | PubMed |
| 39631832 | [Progress in the Study of Mechanisms Clinically Relevant to Insulin Resistance and Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2024 | https://conductscience.org/library/papers/39631832 | PubMed |
| 38783892 | CD44 and its implication in neoplastic diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/38783892 | PubMed |
| 38732252 | Amyloid Beta Leads to Decreased Acetylcholine Levels and Non-Small Cell Lung Cancer Cell Survival via a Mechanism That Involves p38 Mitogen-Activated Protein Kinase and Protein Kinase C in a p53-Dependent and -Independent Manner. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38732252 | PubMed |
| 38571347 | Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38571347 | PubMed |
| 38418632 | The role of leptin in regulation of the soluble amyloid precursor protein α (sAPPα) levels in lung cancer cell media. | Sci Rep | 2024 | https://conductscience.org/library/papers/38418632 | PubMed |
| 38067204 | Regulation of Vascular Endothelial Growth Factor Signaling by Nicotine in a Manner Dependent on Acetylcholine-and/or β-Adrenergic-Receptors in Human Lung Cancer Cells. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/38067204 | PubMed |
| 37760996 | Regulation of Soluble E-Cadherin Signaling in Non-Small-Cell Lung Cancer Cells by Nicotine, BDNF, and β-Adrenergic Receptor Ligands. | Biomedicines | 2023 | https://conductscience.org/library/papers/37760996 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36766747
GET https://conductscience.org/api/papers/v1/36766747/references?page=2